Dehydroepiandrosterone sulphate interferes with the Abbott Architect direct immunoassay for testosterone

M. H. Warner, J. W. Kane, Stephen Atkin, E. S. Kilpatrick

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Background: There are known difficulties in measuring testosterone in women using 'direct' (non-extraction) immunoassays. The positive bias encountered in many of these assays has been attributed to an unidentified interfering substance. We have evaluated the potential for dehydroepiandrosterone sulphate (DHEA-S) to cross-react in the Abbott Architect testosterone assay. Methods: Samples (n=81) from female patients who had DHEA-S, direct and extracted testosterone measured were examined retrospectively. Possible cross-reactivity was evaluated by spiking both testosterone free assay diluent and serum from a woman with exogenous DHEA-S. Results: The retrospective patient analysis of the data demonstrated a relationship between interference and DHEA-S (r=0.78, P≤0.0001). Spiking studies revealed a linear relationship between added DHEA-S and the measured testosterone concentration. Consistent with the retrospective study, for every 1 μmol/L increase in DHEA-S, 0.23 nmol/L of testosterone was measured in the diluent. Spiking DHEA-S into serum gave only a 0.12 nmol/L increase in measured testosterone for every 1 μmol/L rise in DHEA-S. Conclusion: DHEA-S cross-reacts in the Abbott Architect direct immunoassay for testosterone to a clinically significant effect. This cross-reactivity is likely to be responsible for much of the interference observed when measuring testosterone in women by this method.

Original languageEnglish
Pages (from-to)196-199
Number of pages4
JournalAnnals of Clinical Biochemistry
Volume43
Issue number3
DOIs
Publication statusPublished - May 2006
Externally publishedYes

Fingerprint

Dehydroepiandrosterone Sulfate
Immunoassay
Testosterone
Assays
Dehydroepiandrosterone
Serum
Retrospective Studies

ASJC Scopus subject areas

  • Clinical Biochemistry

Cite this

Dehydroepiandrosterone sulphate interferes with the Abbott Architect direct immunoassay for testosterone. / Warner, M. H.; Kane, J. W.; Atkin, Stephen; Kilpatrick, E. S.

In: Annals of Clinical Biochemistry, Vol. 43, No. 3, 05.2006, p. 196-199.

Research output: Contribution to journalArticle

@article{4daa490e060948c9ade3905c6d7d37e7,
title = "Dehydroepiandrosterone sulphate interferes with the Abbott Architect direct immunoassay for testosterone",
abstract = "Background: There are known difficulties in measuring testosterone in women using 'direct' (non-extraction) immunoassays. The positive bias encountered in many of these assays has been attributed to an unidentified interfering substance. We have evaluated the potential for dehydroepiandrosterone sulphate (DHEA-S) to cross-react in the Abbott Architect testosterone assay. Methods: Samples (n=81) from female patients who had DHEA-S, direct and extracted testosterone measured were examined retrospectively. Possible cross-reactivity was evaluated by spiking both testosterone free assay diluent and serum from a woman with exogenous DHEA-S. Results: The retrospective patient analysis of the data demonstrated a relationship between interference and DHEA-S (r=0.78, P≤0.0001). Spiking studies revealed a linear relationship between added DHEA-S and the measured testosterone concentration. Consistent with the retrospective study, for every 1 μmol/L increase in DHEA-S, 0.23 nmol/L of testosterone was measured in the diluent. Spiking DHEA-S into serum gave only a 0.12 nmol/L increase in measured testosterone for every 1 μmol/L rise in DHEA-S. Conclusion: DHEA-S cross-reacts in the Abbott Architect direct immunoassay for testosterone to a clinically significant effect. This cross-reactivity is likely to be responsible for much of the interference observed when measuring testosterone in women by this method.",
author = "Warner, {M. H.} and Kane, {J. W.} and Stephen Atkin and Kilpatrick, {E. S.}",
year = "2006",
month = "5",
doi = "10.1258/000456306776865034",
language = "English",
volume = "43",
pages = "196--199",
journal = "Annals of Clinical Biochemistry",
issn = "0004-5632",
publisher = "SAGE Publications Ltd",
number = "3",

}

TY - JOUR

T1 - Dehydroepiandrosterone sulphate interferes with the Abbott Architect direct immunoassay for testosterone

AU - Warner, M. H.

AU - Kane, J. W.

AU - Atkin, Stephen

AU - Kilpatrick, E. S.

PY - 2006/5

Y1 - 2006/5

N2 - Background: There are known difficulties in measuring testosterone in women using 'direct' (non-extraction) immunoassays. The positive bias encountered in many of these assays has been attributed to an unidentified interfering substance. We have evaluated the potential for dehydroepiandrosterone sulphate (DHEA-S) to cross-react in the Abbott Architect testosterone assay. Methods: Samples (n=81) from female patients who had DHEA-S, direct and extracted testosterone measured were examined retrospectively. Possible cross-reactivity was evaluated by spiking both testosterone free assay diluent and serum from a woman with exogenous DHEA-S. Results: The retrospective patient analysis of the data demonstrated a relationship between interference and DHEA-S (r=0.78, P≤0.0001). Spiking studies revealed a linear relationship between added DHEA-S and the measured testosterone concentration. Consistent with the retrospective study, for every 1 μmol/L increase in DHEA-S, 0.23 nmol/L of testosterone was measured in the diluent. Spiking DHEA-S into serum gave only a 0.12 nmol/L increase in measured testosterone for every 1 μmol/L rise in DHEA-S. Conclusion: DHEA-S cross-reacts in the Abbott Architect direct immunoassay for testosterone to a clinically significant effect. This cross-reactivity is likely to be responsible for much of the interference observed when measuring testosterone in women by this method.

AB - Background: There are known difficulties in measuring testosterone in women using 'direct' (non-extraction) immunoassays. The positive bias encountered in many of these assays has been attributed to an unidentified interfering substance. We have evaluated the potential for dehydroepiandrosterone sulphate (DHEA-S) to cross-react in the Abbott Architect testosterone assay. Methods: Samples (n=81) from female patients who had DHEA-S, direct and extracted testosterone measured were examined retrospectively. Possible cross-reactivity was evaluated by spiking both testosterone free assay diluent and serum from a woman with exogenous DHEA-S. Results: The retrospective patient analysis of the data demonstrated a relationship between interference and DHEA-S (r=0.78, P≤0.0001). Spiking studies revealed a linear relationship between added DHEA-S and the measured testosterone concentration. Consistent with the retrospective study, for every 1 μmol/L increase in DHEA-S, 0.23 nmol/L of testosterone was measured in the diluent. Spiking DHEA-S into serum gave only a 0.12 nmol/L increase in measured testosterone for every 1 μmol/L rise in DHEA-S. Conclusion: DHEA-S cross-reacts in the Abbott Architect direct immunoassay for testosterone to a clinically significant effect. This cross-reactivity is likely to be responsible for much of the interference observed when measuring testosterone in women by this method.

UR - http://www.scopus.com/inward/record.url?scp=33646372454&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646372454&partnerID=8YFLogxK

U2 - 10.1258/000456306776865034

DO - 10.1258/000456306776865034

M3 - Article

VL - 43

SP - 196

EP - 199

JO - Annals of Clinical Biochemistry

JF - Annals of Clinical Biochemistry

SN - 0004-5632

IS - 3

ER -